518 related articles for article (PubMed ID: 22974781)
1. Treatment of lung cancer.
Gadgeel SM; Ramalingam SS; Kalemkerian GP
Radiol Clin North Am; 2012 Sep; 50(5):961-74. PubMed ID: 22974781
[TBL] [Abstract][Full Text] [Related]
2. [Combined-modality therapy for lung cancer].
Miura S; Yamamoto N
Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
[TBL] [Abstract][Full Text] [Related]
3. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Bunn PA
Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced (stages III and IV) non-small-cell lung cancer.
Sweeney CJ; Sandler AB
Curr Probl Cancer; 1998; 22(2):85-132. PubMed ID: 9580849
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.
Stupp R; Mayer M; Kann R; Weder W; Zouhair A; Betticher DC; Roth AD; Stahel RA; Majno SB; Peters S; Jost L; Furrer M; Thierstein S; Schmid RA; Hsu-Schmitz SF; Mirimanoff RO; Ris HB; Pless M
Lancet Oncol; 2009 Aug; 10(8):785-93. PubMed ID: 19604722
[TBL] [Abstract][Full Text] [Related]
6. [Combined modality therapy for small cell lung cancer patient with limited stage disease].
Wang HJ; Sun KL; Zhang XR; Sun Y; Shi YK
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):701-3. PubMed ID: 18246803
[TBL] [Abstract][Full Text] [Related]
7. Combined modality therapy of non-small cell lung cancers.
Juretic A; Sobat H; Samija M
Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
[TBL] [Abstract][Full Text] [Related]
8. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
9. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
10. Lung Cancer: Management.
Mott TF
FP Essent; 2018 Jan; 464():27-30. PubMed ID: 29313655
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer: a review of current therapeutic modalities.
Sandler AB; Buzaid AC
Lung; 1992; 170(5):249-65. PubMed ID: 1325579
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
13. Treatment options in stage III non-small cell lung cancer.
Paraschiv B; Diaconu CC; Dumitrache-Rujinski S; Belaconi IN; Constantinescu T; Stroescu CC; Dantes E; Fildan AP; Bogdan MA; Toma CL
Pneumologia; 2016; 65(2):67-70. PubMed ID: 29538961
[TBL] [Abstract][Full Text] [Related]
14. Combined modality therapy for non-small cell lung carcinoma.
Machtay M; Glatstein E
Cancer J; 2002; 8 Suppl 1():S55-67. PubMed ID: 12075703
[TBL] [Abstract][Full Text] [Related]
15. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
Johnson DH; Rusch VW; Turrisi AT
J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
[No Abstract] [Full Text] [Related]
16. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
17. Combined modality therapy for stage III non-small-cell lung cancer.
Anderson CS; Curran WJ
Semin Radiat Oncol; 2010 Jul; 20(3):186-91. PubMed ID: 20685581
[TBL] [Abstract][Full Text] [Related]
18. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
Saka H; Kitagawa C; Ichinose Y; Takenoyama M; Ibata H; Kato T; Takami K; Yamashita M; Maeda T; Takeo S; Ueda H; Okabayashi K; Nagashima S; Oka T; Kouso H; Fukuyama S; Yoshimoto K; Shimokawa M; Saito AM; Ito S
Trials; 2017 Sep; 18(1):429. PubMed ID: 28915900
[TBL] [Abstract][Full Text] [Related]
19. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
Hoffmann H
Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
[TBL] [Abstract][Full Text] [Related]
20. Current status of induction treatment for N2-Stage III non-small cell lung cancer.
Yamaguchi M; Sugio K
Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):651-9. PubMed ID: 25355643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
